S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
NYSE:CANO

Cano Health (CANO) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
$2.00
$9.31
52-Week Range
N/A
Volume
159,142 shs
Average Volume
423,785 shs
Market Capitalization
$12.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.85

Cano Health MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.67 Rating Score
Upside/​Downside
∞ Upside
$1.85 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$1.68 M Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($2.01) to ($29.82) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.72 out of 5 stars

Medical Sector

853rd out of 939 stocks

Offices & Clinics Of Medical Doctors Industry

6th out of 7 stocks

CANO stock logo

About Cano Health Stock (NYSE:CANO)

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.

CANO Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
American League East Preview Capsules
Firm Retention Summary: Cano Health
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Cano Health Secures $150M in Crucial Financing Deal
Cano Health's fall from grace
Cano Health Receives NYSE Delisting Notice Post-Bankruptcy
Cano Health Strikes Restructuring Deal Amid Bankruptcy
Cano Health files bankruptcy to restructure its debt
Why Is Cano Health (CANO) Stock Down 51% Today?
See More Headlines
Receive CANO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cano Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Fax
N/A
Employees
4,365
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.85
High Stock Price Target
$3.75
Low Stock Price Target
$0.80
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

Net Income
$-207,270,000.00
Pretax Margin
-36.27%

Debt

Sales & Book Value

Annual Sales
$2.74 billion
Book Value
$100.28 per share

Miscellaneous

Free Float
4,653,000
Market Cap
$12.39 million
Optionable
Optionable
Beta
0.05
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

CANO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cano Health stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cano Health in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" CANO shares.
View CANO analyst ratings
or view top-rated stocks.

What is Cano Health's stock price target for 2024?

3 analysts have issued 12 month price objectives for Cano Health's stock. Their CANO share price targets range from $0.80 to $3.75. On average, they expect the company's share price to reach $1.85 in the next year.
View analysts price targets for CANO
or view top-rated stocks among Wall Street analysts.

Who are Cano Health's major shareholders?

Cano Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.42%), Cutler Group LLC CA (0.00%), GTS Securities LLC (0.00%), Wolverine Trading LLC (0.00%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Brian D Koppy, David J Armstrong, Elliot Cooperstone, Lewis Gold, Marlow Hernandez, Richard Aguilar, Robert Camerlinck and Solomon D Trujillo.
View institutional ownership trends
.

How do I buy shares of Cano Health?

Shares of CANO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CANO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners